首頁 > 市場調查報告書 > 醫療設備

醫院 IT 癌症

市場調查報告書

商品編碼

1458171

腫瘤資訊系統的全球市場規模、佔有率和成長分析：按產品、應用和最終用戶 - 產業預測（2024-2031）

Global Oncology Information Systems Market Size, Share, Growth Analysis, By Product, By Application, By End User - Industry Forecast 2024-2031

出版日期: 2024年03月24日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球腫瘤資訊系統市場規模到2022年達到25億美元，在預測期（2024-2031年），將從2023年的27億美元成長到2031年的49.6億美元，預計複合年成長率為7.9 % 。

預計推動市場擴張的關鍵因素包括全球癌症發病率上升、與開發癌症治療方法和解決方案相關的成本上升以及醫療機構普及OIS治療方法。據 percancer.org 稱，到 2021 年，僅在美國就會增加近 190 萬名癌症患者。許多新技術正在開發中，有可能從根本上改變治療策略。對 OIS 軟體簡化病患資料和資訊管理流程的需求日益成長，也增加了對各種型態的OIS 軟體的需求。企業對癌症研究的投資增加預計將有助於市場擴張。預計未來幾年市場將顯著成長，企業正積極投資新穎性科技產品的開發。由於資本和資源大量湧入醫療保健行業，特別是癌症檢測行業，大公司對 OIS 開發的投資似乎具有巨大潛力。到2024-2025年，英國政府計劃投資260億美元研發。政府的生命科學視覺與癌症研究計畫已獲得生命科學部 1.235 億美元的津貼。這些舉措以及各公司推出的新軟體和產品應該會推動市場成長。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2021年）
主要市場參與者所採取的策略
關鍵成功策略
近期市集活動
主要企業市場佔有率（2021年）

主要企業簡介

Epic Systems Corporation
Cerner Corporation
Elekta AB
Varian Medical Systems, Inc.
Philips Healthcare
McKesson Corporation
GE Healthcare
Siemens Healthineers
Accuray Incorporated
RaySearch Laboratories AB
CureMD Healthcare
Flatiron Health, Inc.
MIM Software Inc.
Elekta Inc.
IBM Watson Health
Impac Software（Varian）
EpicCare Oncology
RayCare（RaySearch）
MOSAIQ Oncology（Elekta）
OncoEMR（CureMD）

簡介目錄

Product Code: SQMIG35A2458

Global Oncology Information Systems Market size was valued at USD 2.5 billion in 2022 and is poised to grow from USD 2.7 billion in 2023 to USD 4.96 billion by 2031, growing at a CAGR of 7.9% during the forecast period (2024-2031).

Some of the major drivers anticipated to propel market expansion are the rising incidence of cancer worldwide, rising costs associated with developing cancer therapies and solutions, and the growing uptake of OIS cures by healthcare facilities. By 2021, nearly 1.9 million more cases of cancer are anticipated to be discovered in the US alone, according to percancer.org. Numerous novel technologies are under development that could fundamentally alter the course of treatment. The necessity for various forms of OIS software has increased due to the growing need for OIS software to help streamline the process of patient data and information management. Market expansion is anticipated to be aided by companies' increased investment in cancer research. It is anticipated that the market will grow greatly in the upcoming years, and businesses are actively investing in the development of novel, highly technology products. Large companies' investments in OIS development will have enormous potential due to a significant influx of capital and resources for the healthcare sector, especially in the area of cancer detection. By 2024-2025, the UK government plans to invest $26 billion in research and development. The government's Life Sciences Vision & cancer research program has received a grant of USD 123.5 million from the Office for Life Sciences. Such initiatives, along with the introduction of new software and products by different businesses, should encourage market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oncology Information Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Oncology Information Systems Market Segmental Analysis

Global Oncology Information Systems Market is segmented based Product, Application, End User and region. Based On Product the market is segmented into Solutions, Professional Services. Based on Application the market is segmented into Medical Oncology, Radiation Oncology, Surgical Oncology. Based on End User the market is segmented into Hospitals & Diagnostic Imaging Centers, Ablation Care Centers and Cancer Care Centers, Government Institutions, Research Facilities. Based on region the global Oncology Information Systems Market is segmented into North America, Europe, Asia-Pacific, South America, and MEA.

Drivers of the Global Oncology Information Systems Market

The capabilities of OIS have been significantly improved by the ongoing developments in healthcare technology, including the incorporation of big data analytics, machine learning, and artificial intelligence (AI). Better patient outcomes, tailored treatment plans, and more precise diagnoses are made possible by these technological advancements.

Restraints in the Global Oncology Information Systems Market

OIS implementation and upkeep can be costly, particularly for smaller healthcare facilities. Organizations with limited funds may face difficulties covering the initial outlay, software licensing, physical infrastructure, training, and continuing maintenance expenses.

Market Trends of the Global Oncology Information Systems Market

The use of cloud-based cancer information systems by healthcare professionals is becoming more and more common. Cloud-based solutions enable healthcare organizations to securely store and retrieve patient data from any location, all while offering scalability, flexibility, and cost effectiveness. It also makes it easier for the many parties engaged in cancer care to collaborate and share data in an easy way.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Oncology Information Systems Market by Product

Market Overview
Solutions
and Professional Services

Global Oncology Information Systems Market by Application

Market Overview
Medical Oncology
Radiation Oncology
and Surgical Oncology

Global Oncology Information Systems Market by End User

Market Overview
Hospitals & Diagnostic Imaging Centers
Ablation Care Centers and Cancer Care Centers
Government Institutions
and Research Facilities

Global Oncology Information Systems Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Epic Systems Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cerner Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elekta AB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Varian Medical Systems, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Philips Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
McKesson Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Accuray Incorporated
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RaySearch Laboratories AB
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CureMD Healthcare
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Flatiron Health, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MIM Software Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elekta Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IBM Watson Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Impac Software (Varian)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EpicCare Oncology
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RayCare (RaySearch)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MOSAIQ Oncology (Elekta)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OncoEMR (CureMD)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments